The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study

Circulation

Volumn 127, Issue 2, 2013, Pages 180-187

  Purnell, Jonathan Q ^a   John E Hokanson, ^b   Cleary, Patricia A ^c   Nathan, David M ^d   Lachin, John M ^b   Zinman, Bernard ^e   Brunzell, John D ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

calcium; carotid intima media thickness; coronary vessels; diabetes mellitus, type 1; imaging, diagnostic; obesity

Indexed keywords

CALCIUM; INSULIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; WAIST CIRCUMFERENCE; WEIGHT GAIN; YOUNG ADULT;

EID: 84872303256     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.077487     Document Type: Article

References (34)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mel-litus. The diabetes control and complications trial research group. N Engl J Med. 1993;329:977-986.
2. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol. 1995;75:894-903.
3. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM. The effect of intensive glycemic treatment on coronary artery calcifcation in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes. 2006;55:3556-3565.
4. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348:2294-2303.
5. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643-2653.
6. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brun-zell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the DCCT. Diabetes Control and Complications Trial. JAMA. 1998;280:140-146.
7. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). Jama. 2001;285:2486-2497.
8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
9. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601-2607.
10. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: A 12-year prospective evaluation of three separate def-nitions of the metabolic syndrome and their components and estimated glucose disposal rate: The Pittsburgh epidemiology of diabetes complications study experience. Diabetes Care. 2007;30:1248-1254.
11. Thorn LM, Forsblom C, Waden J, Saraheimo M, Tolonen N, Hietala K, Groop PH. Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2009;32:950-952.
12. Purnell JQ, Dev RK, Steffes MW, Cleary PA, Palmer JP, Hirsch IB, Ho-kanson JE, Brunzell JD. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the diabetes control and complications trial. Diabetes. 2003;52:2623-2629.
13. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) research group. Diabetes. 1999;48:383-390.
14. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M. Evaluating changes in coronary artery calcium: An analytic method that accounts for interscan variability. AJR Am J Roentgenol. 2004;182:1327-1332.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
16. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT research group. Diabetes. 1986;35:530-545.
17. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest. 1991;21:161-167.
18. Sibley SD, Palmer JP, Hirsch IB, Brunzell JD. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab. 2003;88:3379-3384.
19. Mowri HO, Patsch JR, Ritsch A, Foger B, Brown S, Patsch W. High density lipoproteins with differing apolipoproteins: Relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: Cholesterol acyltransferase. J Lipid Res. 1994;35:291-300.
20. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. A novel endothelial-derived lipase that modulates HDL metabolism. Nature genetics. 1999;21:424-428.
21. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
22. Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr. 2004;145:452-457.
23. Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2006;74:33-40.
24. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grun-dy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS, Harrington RA, Abrams J, Anderson JL, Bates ER, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofeld RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography). Circulation. 2007;115:402-426.
25. Snell-Bergeon JK, Hokanson JE, Jensen L, MacKenzie T, Kinney G, Da-belea D, Eckel RH, Ehrlich J, Garg S, Rewers M. Progression of coronary artery calcifcation in type 1 diabetes: the importance of glycemic control. Diabetes Care. 2003;26:2923-2928.
26. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
27. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, Orchard TJ. Adiposity and mortality in type 1 diabetes. Int J Obes (Lond). 2009;33:796-805.
28. Perusse L, Despres JP, Lemieux S, Rice T, Rao DC, Bouchard C. Familial aggregation of abdominal visceral fat level: results from the Quebec family study. Metabolism. 1996;45:378-382.
29. Perusse L, Rice T, Despres JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the heritage family study. Arterioscler Thromb Vasc Biol. 1997;17:3263-3269.
30. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L, Bouchard C. The human obesity gene map: The 2005 update. Obesity (Silver Spring). 2006;14:529-644.
31. Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL. Heri-tabilities of the metabolic syndrome and its components in the northern Manhattan family study. Diabetologia. 2005;48:2006-2012.
32. Thorn LM, Forsblom C, Waden J, Soderlund J, Rosengard-Barlund M, Saraheimo M, Heikkila O, Hietala K, Pettersson-Fernholm K, Ilonen J, Groop PH. Effect of parental type 2 diabetes on offspring with type 1 diabetes. Diabetes Care. 2009;32:63-68.
33. Erbey JR, Kuller LH, Becker DJ, Orchard TJ. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care. 1998;21:610-614.
34. Deeb SS, Brunzell JD. The role of the pgc1alpha gly482ser polymorphism in weight gain due to intensive diabetes therapy. PPAR Res. 2009:649286, 2009.